Design, synthesis, and evaluation of novel stilbene derivatives that degrade acidic nucleoplasmic DNA-binding protein 1 (And1) and synergize with PARP1 inhibitor in NSCLC cells
Specifically inducing the degradation of acidic nucleoplasmic DNA-binding protein 1 (And1) is a promising antitumor strategy. Our previous study identified Bazedoxifene (BZA) and CH3 as specific And1 degraders and validated their activity in reversing radiotherapy resistance in vitro and in vivo. Ho...
Saved in:
Main Authors: | Leyuan Chen (Author), Zhonghao Ren (Author), Yunze Zhang (Author), Wenbin Hou (Author), Yiliang Li (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design and synthesis of benzodiazepines as brain penetrating PARP-1 inhibitors
by: Jiang Yu, et al.
Published: (2022) -
Identification of probe-quality degraders for Poly(ADP-ribose) polymerase-1 (PARP-1)
by: Zhimin Zhang, et al.
Published: (2020) -
Alkannin-Induced Oxidative DNA Damage Synergizes With PARP Inhibition to Cause Cancer-Specific Cytotoxicity
by: Mingxin Chang, et al.
Published: (2020) -
Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradation
by: Barbora Orlikova-Boyer, et al.
Published: (2024) -
SIRT1 activation synergizes with FXR agonism in hepatoprotection via governing nucleocytoplasmic shuttling and degradation of FXR
by: Shuang Cui, et al.
Published: (2023)